Queen Elizabeth Medical Centre, Birmingham
- Useful links:
This hospital is part of University Hospital Birmingham NHS Foundation Trust
General hospital information
- Number of beds: N/A
- % of single rooms: N/A
- Total parking spaces: N/A
- Average parking fee per hour: N/A
Address & description
University Hospital Birmingham NHS Foundation Trust runs two hospitals, the Queen Elizabeth and Selly Oak, which are situated 1.5 miles apart in South Birmingham. The principal activities of the Trust are to provide healthcare for the local population of South Birmingham, to provide general and specialist healthcare for a local, regional and, in certain specialities, a national population. It is also to provide an environment for teaching medical, nursing and allied health professionals and for clinical research.
As a specialist teaching Trust, UHB provides a wide range of hospital services:
- District hospital services, catering for the vast majority of everyday acute health needs among the adult population of South and Central Birmingham
- Regional services such as renal, cancer, neurosciences, burns and cardiac services for the population of the West Midlands
- Supra-regional services, including liver and heart transplant programmes, for patients throughout the UK
On the Queen Elizabeth Site the following services are provided:
- General and Breast Surgery
- Neurosciences
- Cardiac Services
- Renal/Urology Services
- Liver
- ENT & Maxillofacial Services
- Endocrinology
- GI Medicine and Surgery
- Oncology
- QED (Quick and Early Diagnosis Unit)
- Haematology
- Respiratory Centre
- Critical Care
Over 525,000 patients came to UHB for their care in the last 12 months, ranging from simple outpatient appointments to major life-saving procedures.
UHB is the leading teaching hospital in the West Midlands and this year received 'excellent' for its financial management and 'good' for the quality of its clinical and non-clinical services in the Healthcare Commission's Annual Health Check.
UHB has very close links to the University of Birmingham and Birmingham City University and therefore its aims are not simply to provide the best possible care but also to make sure that it fulfils its leading role in teaching medical and nursing students and in providing a base for excellent research.
Complementing its role as a centre of excellence, it also aims to be an asset to the communities of Birmingham and the West Midlands.
UHB is also proud to host the Royal Centre for Defence Medicine (RCDM). The RCDM provides dedicated training for defence personnel and is a focus for medical research. Whilst the RCDM is based at Selly Oak Hospital, defence personnel are fully integrated throughout both sites and treat both military and civilian patients.
Medical military staff also gain valuable experience working in an NHS hospital equipping them with the skills needed to take with them to theatre in war zones.
The Wellcome Trust Clinical Research Facility (CRF) is also hosted by the Trust at the Queen Elizabeth Hospital and is Britain's largest biomedical charity. This development is a joint initiative between UHB and the University of Birmingham Medical School.
The Trust has around 82,000 members and a Board of Governors which includes 24 members of the public (local people, patients and staff), who have been elected as representatives. It serves an ethnically diverse community and this is reflected in its membership and in its Board of Governors.
UHB's ambitions are incorporated into its strategic aims, which also form the framework for annual and medium term planning. Our Annual Plan is available on the Trust's website www.uhb.nhs.uk.
In November 2007 the Birmingham Clinical Research Academy (BCRA) was launched. The Academy, which is led by UHB and the University of Birmingham, is working with Aston and Birmingham City universities to establish a world-class medical, technology research and training centre in the region - the UK's medical Harvard. It is hoped that other healthcare organisations will get involved in the Academy in the near future.
* this profile text was provided by University Hospital Birmingham NHS Foundation Trust
Consultants at Queen Elizabeth Medical Centre
The consultants listed below work at this hospital. If you can't find the consultant you're looking for, visit the consultant guide to search our directory of more than 35,000 consultants working in the UK consultant guide.
Filter by specialty:
Accident & Emergency services at Queen Elizabeth Medical Centre
cardiac services (heart attack) |
National average | |
|---|---|---|
| Patients having thrombolytic treatment within 30 minutes of arriving at hospital |
N/A
 The National Service Framework (NSF) for coronary heart disease (CHD) states that 75% of eligible heart attack patients in England should receive thrombolytic drugs within 30 minutes of arriving at hospital. Read more about this indicator.
|
75% |
| Patients having thrombolytic treatment within 60 minutes of calling for help |
N/A
This standard reflects the combined performance of the ambulance service, general practitioners (GPs) and hospitals and is the most relevant overall indicator of care of heart attack patients. It encourages collaborative working across all relevant NHS organisations, particularly between ambulance services and hospitals to reduce delays to thrombolytic treatment. The call for professional help will usually be direct to the ambulance service but may be to a GP or NHS Direct. The Department of Health has set NHS organisations in England the target of 68% of patients receiving thrombolytic treatment within 60 minutes of calling for professional help. Read more about this indicator
|
68% |
| Primary angioplasty within 90 minutes of arrival at interventional centre door |
68%
An interim good practice standard of 90 minutes from arrival at an interventional hospital to the time when the blocked artery is reopened (door to balloon time) has been established for provision of primary angioplasty, based on international guidelines.
|
90% |
| Patients discharged from hospital on secondary prevention medication | ||
| Asprin | 100% | 99% |
| Beta blocker | 99% | 96% |
| Statins | 100% | 97% |
| ACE inhibitor | 100% | 94% |
| Clopidogrel | 100% | 95% |